Years of research laid the groundwork for speedy COVID-19 shots
1 year, 2 months ago

Years of research laid the groundwork for speedy COVID-19 shots

Associated Press  

The Nobel Prize in Medicine was awarded Monday to two scientists whose work led to the mRNA vaccines against COVID-19. “Abject giddiness,” is how Dr. C. Buddy Creech, a Vanderbilt University vaccine expert, described scientists’ reactions when separate studies showed the two candidates were about 95% effective. Billions in company and government funding certainly sped up vaccine development — and the unfortunately huge number of infections meant scientists didn’t have to wait long to learn the shots appeared to be working. “Instead of growing up a virus in a 50,000-liter drum and inactivating it, we could deliver RNA and our bodies make the protein, which starts the immune response,” said Penn’s Dr. Drew Weissman. Meanwhile at the NIH, Dr. Barney Graham’s team figured out the right target — how to use the aptly named “spike” protein that coats the coronavirus to properly prime the immune system.

Research Work Vaccines Covid Graham Penn Protein Scientists Vaccine Mrna Moderna Shots Nih Pfizer Rna  groundwork  research  dr  vaccine  covid19  way  protein  vaccines  laid  scientists  rna  speedy  work  mrna  shots

History of this topic

COVID is getting so bad, new vaccines were given early emergency approval
4 months ago

COVID is getting so bad, new vaccines were given early emergency approval

Salon  

This summer's COVID-19 wave has gotten so bad — even worse than winter peaks in some regions — the U.S. Food and Drug Administration announced they are approving two vaccines early, but leaving one out for now. Given waning immunity of the population from previous exposure to the virus and from prior vaccination, we strongly encourage those who are eligible …

New push for mRNA bird flu vaccine development: WHO
4 months, 3 weeks ago

New push for mRNA bird flu vaccine development: WHO

The Hindu  

The World Health Organisation announced Monday, July 29, 2024, a new project to accelerate the development in poorer countries, of vaccines for human bird flu infections, using cutting-edge messenger RNA technology. Vaccine equity Swiftly developed mRNA Covid vaccines were game-changers during the pandemic, but they also exposed glaring global vaccine inequity and demands for a fairer distribution amid efforts to …

Scientists are testing mRNA vaccines to protect cows and people against bird flu
6 months, 3 weeks ago

Scientists are testing mRNA vaccines to protect cows and people against bird flu

Associated Press  

The bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA vaccines — akin to COVID-19 shots — that are being tested in both animals and people. the U.S. Department of Health and Human Services has been talking to manufacturers about possible mRNA flu vaccines for people that, if needed, could supplement millions of bird flu …

Beyond COVID-19 vaccines: what else could mRNA technology do for our health?
1 year, 2 months ago

Beyond COVID-19 vaccines: what else could mRNA technology do for our health?

The Hindu  

Many people first became familiar with the term “mRNA” when Pfizer’s and Moderna’s COVID-19 vaccines were rolled out. In the simplest terms, mRNA, which stands for messenger ribonucleic acid, is a type of genetic material that gives cells in our bodies instructions to make specific proteins. So it was pivotal when Karakó and Weissman pioneered a technique to “cloak” mRNA …

Gates Foundation funding $40 million effort to help develop mRNA vaccines in Africa in coming years
1 year, 2 months ago

Gates Foundation funding $40 million effort to help develop mRNA vaccines in Africa in coming years

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy A $40 million investment will …

How was mRNA research used to fight COVID? | Explained
1 year, 2 months ago

How was mRNA research used to fight COVID? | Explained

The Hindu  

The story so far: On October 2, Nobel Prize week began with the 2023 Prize in Physiology or Medicine being awarded to Katalin Karikó and Drew Weissman. They were awarded the prize for their “discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19”. However, while most vaccines use weakened or dead bacteria or viruses …

Shot in the arm: On the Medicine Nobel 2023
1 year, 2 months ago

Shot in the arm: On the Medicine Nobel 2023

The Hindu  

All nominees for the Nobel Prize in Physiology or Medicine have path-breaking achievements to their credit, but often, the final choice of the winner might have a lot to do with the timing and the context. Katalin Karikó and Drew Weissman would have thus been safe bets for their work that enabled the development of effective mRNA vaccines against COVID-19. …

The trouble with a Nobel for mRNA COVID vaccines
1 year, 2 months ago

The trouble with a Nobel for mRNA COVID vaccines

The Hindu  

The 2023 Nobel Prize for Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for developing the mRNA vaccine technology that became the foundation for history’s fastest vaccine development programme during the COVID-19 pandemic. Once Moderna and Pfizer began producing their mRNA COVID-19 vaccines, they were also mired in North American and European countries’ zeal to make …

Perseverance counts: A Nobel for mRNA vaccines is welcome
1 year, 2 months ago

Perseverance counts: A Nobel for mRNA vaccines is welcome

Live Mint  

This year’s Nobel Prize in medicine is a testament to the power of perseverance in science. By swapping out a basic building block of mRNA called uridine for a related molecule called pseudouridine, strands of mRNA could get their message to cells without triggering an immune attack. That discovery helped spawn the earliest biotech companies working on the technology, thus …

Nobel medicine prize: How two scientists modified mRNA for vaccine breakthrough
1 year, 2 months ago

Nobel medicine prize: How two scientists modified mRNA for vaccine breakthrough

Hindustan Times  

In the battle against Covid-19, one of the gamechangers has been the mRNA vaccine, which was rolled out and administered in quick time. Scientists Katalin Kariko and Drew Weissman, who won the 2023 Nobel Prize in Physiology or Medicine for discoveries enabling the development of mRNA COVID-19 vaccines, speak during a news conference hosted by the University of Pennsylvania and …

Katalin Karikó’s Nobel Prize Marks the Beginning of an mRNA Vaccine Revolution
54 years, 11 months ago

Katalin Karikó’s Nobel Prize Marks the Beginning of an mRNA Vaccine Revolution

Wired  

No one expected the first Covid-19 vaccine to be as good as it was. “We were hoping for around 70 percent, that’s a success,” says Dr Ann Falsey, a professor of medicine at the University of Rochester, New York, who ran a 150-person trial site for the Pfizer-BioNTech vaccine in 2020. All the preliminary laboratory tests looked good; having seen …

Medicine Nobel for the technology that turned the pandemic
1 year, 2 months ago

Medicine Nobel for the technology that turned the pandemic

The Hindu  

The 2023 Nobel Prize for physiology or medicine has been awarded to the Hungarian biochemist Katalin Karikó and the American physician-scientist Drew Weissman. The idea was to inject the body with a modified mRNA that would instruct cells to build a certain protein, which could then provoke the body’s immune system to ‘attack’ it as well as prepare itself to …

2023 Nobel Prize in Medicine or Physiology: What are mRNA vaccines and how do they work?
1 year, 2 months ago

2023 Nobel Prize in Medicine or Physiology: What are mRNA vaccines and how do they work?

The Hindu  

The story so far: The 2023 Nobel Prize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their research that enabled the development of mRNA vaccines against COVID-19. However, while most vaccines use weakened or dead bacteria or viruses to evoke a response from the immune system, mRNA vaccines only introduce a piece of the …

Drew Weissman, Nobel-winning mRNA pioneer
1 year, 2 months ago

Drew Weissman, Nobel-winning mRNA pioneer

The Hindu  

Drew Weissman's decades of research into mRNA technology paved the way for Covid-19 vaccines, finally earning a Nobel prize for the physician-scientist. "There have been three pandemics or epidemics in the past 20 years," Weissman told AFP recently, referring to the original SARS virus, MERS and Covid-19. With a second big breakthrough in 2015, they found a new way to …

Explained: What are mRNA vaccines that earned two scientists Nobel in Medicine
1 year, 2 months ago

Explained: What are mRNA vaccines that earned two scientists Nobel in Medicine

Hindustan Times  

The coronavirus pandemic brought global renown to the mRNA technology that underpins vaccines from Pfizer/BioNTech and Moderna, and on Monday earned a Nobel Prize for two scientists who have been key to its development. Penn Medicine scientists Katalin Kariko and Drew Weissman, who won the 2023 Nobel Prize in Physiology or Medicine for discoveries enabling the development of mRNA COVID-19 …

Karikó and Weissman win Nobel Prize in medicine for work that enabled mRNA vaccines against COVID-19
1 year, 2 months ago

Karikó and Weissman win Nobel Prize in medicine for work that enabled mRNA vaccines against COVID-19

Associated Press  

STOCKHOLM — Two scientists won the Nobel Prize in medicine on Monday for discoveries that enabled the creation of mRNA vaccines against COVID-19 that were critical in slowing the pandemic — technology that’s also being studied to fight cancer and other diseases. Dr. Paul Hunter, a professor of medicine at Britain’s University of East Anglia, described the mRNA vaccines made …

Scientists whose work on mRNA paved the way for first COVID-19 vaccines win Nobel Prize
1 year, 2 months ago

Scientists whose work on mRNA paved the way for first COVID-19 vaccines win Nobel Prize

LA Times  

Dr. Drew Weissman, left, a physician-scientist, and biochemist Katalin Karikó won the Nobel Prize in medicine for discoveries that enabled the creation of mRNA vaccines against COVID-19 and that could be used to develop other shots in the future. “This year’s Nobel Prize recognizes their basic science discovery that fundamentally changed our understanding of how mRNA interacts with the immune …

How vaccines helped reshape the course of the Covid-19 pandemic
1 year, 3 months ago

How vaccines helped reshape the course of the Covid-19 pandemic

Hindustan Times  

When future generations look back at the pandemic, they will deem it a black swan event. Let’s delve deep into the crucial role vaccines played in the fight against COVID-19, highlighting their significance in preventing infections, crucial collaborations, the emergence of mRNA as the next big revolution in the vaccine space and more. mRNA vaccines represent a ground-breaking technology that …

Researchers Prepare New mRNA Flu Shot that Can Target All Strains, Prevent Influenza Pandemic
2 years ago

Researchers Prepare New mRNA Flu Shot that Can Target All Strains, Prevent Influenza Pandemic

News 18  

Researchers from the University of Pennsylvania are developing a new mRNA vaccine targeting all known flu strains in a single shot and said the vaccine is showing promise in animal studies. Scott Hensley, an immunologist at the University of Pennsylvania in Philadelphia told CBC: “Our approach was to make a vaccine that encoded every influenza subtype and lineage that we …

Moderna sues Pfizer/BioNTech for patent infringement over COVID-19 vaccine
2 years, 3 months ago

Moderna sues Pfizer/BioNTech for patent infringement over COVID-19 vaccine

The Hindu  

Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. The U.S. Food and Drug Administration granted emergency use authorization for the COVID-19 vaccine first to Pfizer/BioNTech in December 2020, then one week later …

Moderna Sues Pfizer, BioNTech for Covid-19 Vaccine Patent Infringement
2 years, 3 months ago

Moderna Sues Pfizer, BioNTech for Covid-19 Vaccine Patent Infringement

News 18  

Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot that has been administered to hundreds of millions around the world. “Moderna believes that Pfizer and BioNTech’s Covid-19 vaccine Comirnaty infringes patents Moderna filed between 2010 and 2016 covering Moderna’s foundational mRNA technology,” the company said …

Moderna sues Pfizer, BioNTech for Covid-19 vaccine patent infringement
2 years, 3 months ago

Moderna sues Pfizer, BioNTech for Covid-19 vaccine patent infringement

India Today  

Moderna said on Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot administered to hundreds of millions around the world. "Moderna believes that Pfizer and BioNTech's Covid-19 vaccine Comirnaty infringes patents Moderna filed between 2010 and 2016 covering Moderna's foundational mRNA technology," the US-based biotech firm said …

Moderna sues Pfizer, BioNTech for patent infringement over Covid-19 vaccine
2 years, 3 months ago

Moderna sues Pfizer, BioNTech for patent infringement over Covid-19 vaccine

Live Mint  

American pharmaceutical and biotechnology company Moderna has filed a suit in a United States District court against Pfizer and its German partner BioNTech, seeking undetermined damages for patent infringement in the development of the first Covid-19 vaccine. Moderna in a press release informed that they are seeking undetermined monetary damages in the lawsuit filed in the U.S. District Court in …

Moderna sues rival COVID-19 vaccine makers Pfizer and BioNTech
2 years, 3 months ago

Moderna sues rival COVID-19 vaccine makers Pfizer and BioNTech

Al Jazeera  

Moderna previously pledged not to enforce COVID-19-related patents but changed its stance as the pandemic shifted gears. Moderna has said it is suing rival vaccine maker Pfizer and its German partner BioNTech, citing infringement on its patents in developing the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. “Moderna …

India to soon get its first mRNA COVID-19 vaccine: Why is this being touted as a gamechanger?
2 years, 6 months ago

India to soon get its first mRNA COVID-19 vaccine: Why is this being touted as a gamechanger?

Firstpost  

Pune-based Gennova Biopharmaceuticals COVID-19 vaccine, which is awaiting a nod from India’s drug regulators, can be stored at temperatures between 2 and 8 degree Celsius, making its availability in remote areas possible too India’s fight against COVID-19 is about to get a huge push as the country’s first mRNA-based vaccine is one step closer to getting approval. According to reported …

China’s bet on homegrown mRNA vaccines holds back nation
2 years, 7 months ago

China’s bet on homegrown mRNA vaccines holds back nation

Associated Press  

TAIPEI, Taiwan — China is trying to navigate its biggest coronavirus outbreak without a tool it could have adopted many months ago, the kind of vaccines that have proven to offer the best protection against the worst outcomes from COVID-19. “The consequences will be huge, the supply chain disruption, the disruption to all kinds of service sectors.” Studies have consistently …

China’s insistence on a homegrown mRNA vaccine haunts its COVID-control efforts
2 years, 7 months ago

China’s insistence on a homegrown mRNA vaccine haunts its COVID-control efforts

LA Times  

China’s first homegrown mRNA COVID-19 vaccine has yet to undergo all the necessary trials before use. “The consequences will be huge — the supply-chain disruption, the disruption to all kinds of service sectors.” Studies have consistently shown that vaccination with mRNA vaccines made by Pfizer-BioNTech and Moderna offer the best protection against hospitalization and death from COVID-19. The Communist Party-owned …

Hyderabad-based CCMB announces first potential mRNA COVID vaccine
2 years, 7 months ago

Hyderabad-based CCMB announces first potential mRNA COVID vaccine

Firstpost  

Dr N Madhusudan Rao, CEO of Atal Incubation Centre at Centre for Cellular and Molecular Biology, said the mRNA platform has an advantage of flexibility unlike other vaccine platforms New Delhi: Dr N Madhusudan Rao, CEO-Atal Incubation Centre at Centre for Cellular and Molecular Biology on Monday said that India has developed mRNA technology against the COVID-19. The Hyderabad-based Centre …

India develops first mRNA vaccine technology to fight Covid-19
2 years, 7 months ago

India develops first mRNA vaccine technology to fight Covid-19

India Today  

India’s first indigenous mRNA vaccine technology to fight against Covid-19 has been developed by the Centre for Cellular and Molecular Biology and Council Of Scientific And Industrial Research. CSIR-Centre for Cellular and Molecular Biology is leading the development of mRNA vaccine technology in India. However, we lack the potent mRNA vaccine technology, as developed by Moderna or Pfizer/BioNtech to combat …

Hyderabad-based manufacturer to get mRNA technology from WHO to produce COVID-19 vaccines
2 years, 8 months ago

Hyderabad-based manufacturer to get mRNA technology from WHO to produce COVID-19 vaccines

Firstpost  

WHO and their partners will work with the Indian government to develop a roadmap and put in place the necessary training and support for Biological E to start producing mRNA vaccines as soon as possible Hyderabad: Hyderabad-based vaccine manufacturer Biological E on Monday announced that it has been selected as a recipient of mRNA technology from the World Health Organisation …

Biological E. to receive mRNA vaccine tech from WHO
2 years, 8 months ago

Biological E. to receive mRNA vaccine tech from WHO

The Hindu  

Vaccine maker Biological E. has been selected to receive mRNA technology from the World Health Organization technology transfer hub. After examining a number of proposals from India, the WHO's Advisory Committee on Vaccine Product Development has selected Biological E. as a recipient, the Hyderabad–based firm said on Monday. The company has been investing in mRNA technologies since last year and …

COVID: New protein-based vaccine up for approval
2 years, 9 months ago

COVID: New protein-based vaccine up for approval

The Hindu  

Sanofi and GlaxoSmithKline are seeking E.U. and U.S. regulatory approval of their protein-based COVID-19 vaccine, which proved 100 per cent effective at preventing severe illness in phase three clinical trials, the duo announced on Wednesday. Official trial results are yet to be published, but the companies reported that in phase three testing, two doses of the vaccine showed 100 per …

Africa Finds New Tool To Fight Vaccine Inequity As Afrigen Develops mRNA Covid Vaccine
2 years, 10 months ago

Africa Finds New Tool To Fight Vaccine Inequity As Afrigen Develops mRNA Covid Vaccine

News 18  

Despite the world’s major global vaccine companies refusing to share their technology, a South African vaccine manufacturer Afrigen developed its own version of mRNA COVID-19 vaccine. Afrigen used the publicly available sequence of Moderna Inc’s mRNA COVID-19 vaccine and aims to test it on humans by the end of 2022. Afrigen is a part of a consortium brought together by …

US researchers share COVID-19 vaccine with the world
2 years, 11 months ago

US researchers share COVID-19 vaccine with the world

Al Jazeera  

Using traditional technology that can be scaled widely and cheaply, Corbevax offers a potential solution to vaccine inequity. Bypassing the patent restrictions of major pharmaceutical firms, doctors Maria Elena Bottazzi and Peter Hotez at the Baylor College of Medicine and the Texas Children’s Hospital Center for Vaccine Development used traditional vaccine technology that can be deployed rapidly to help inoculate …

Who invented covid-19 vaccines? Drugmakers battle over patents
2 years, 11 months ago

Who invented covid-19 vaccines? Drugmakers battle over patents

Live Mint  

A high-stakes legal battle is taking shape over lucrative patent rights for Covid-19 vaccines, with drug companies pitted against each other and government and academic scientists over who invented what. One dispute stems from Moderna’s decision to deny a National Institutes of Health request to list government scientists as co-inventors on the company’s application for a U.S. patent covering a …

COVID-19: Protein-based vaccines give hope
3 years ago

COVID-19: Protein-based vaccines give hope

The Hindu  

Many people who refuse to get vaccinated against COVID-19 say they don't trust the technology behind mRNA vaccines, such as in BioNTech-Pfizer and Moderna shots. Protein-based vaccines appear to offer a good level of protection against COVID-19 and produce fewer side effects than those existing and approved mRNA and vector-based vaccines. Urgently needed for global vaccine campaign Experts say protein-based …

UK scientists trial first needle-free air-powered COVID-19 vaccine
3 years ago

UK scientists trial first needle-free air-powered COVID-19 vaccine

Live Mint  

Scientists at the University of Cambridge on Tuesday began a clinical trial of a needle-free air-powered vaccine, which is expected to help combat future variants of COVID-19. "It’s vital that we continue to develop new generation vaccine candidates ready to help keep us safe from the next virus threats. Immunisation arms our immune system to look out for and block …

Could mRNA make us superhuman?
3 years, 1 month ago

Could mRNA make us superhuman?

BBC  

Could mRNA make us superhuman? It's such a game changer that it raises some very big, exciting questions: could mRNA vaccines provide a cure for cancers, HIV, tropical diseases, and even give us superhuman immunity? There weren't many people in the mRNA therapeutics world who would have imagined 95% initial efficacy rates – Kathryn Whitehead The theory behind the mRNA …

Africa trying to replicate Moderna's COVID vaccine in an attempt to lessen the gap of vaccine inequity
3 years, 1 month ago

Africa trying to replicate Moderna's COVID vaccine in an attempt to lessen the gap of vaccine inequity

Firstpost  

Some experts see reverse engineering — recreating vaccines from fragments of publicly available information — as one of the few remaining ways to redress the power imbalances of the pandemic. “The United States government has played a very substantial role in making Moderna the company it is,” said David Kessler, the head of Operation Warp Speed, the U.S. program to …

Moderna and Flagship Pioneering: Noubar Afeyan
3 years, 2 months ago

Moderna and Flagship Pioneering: Noubar Afeyan

NPR  

Moderna and Flagship Pioneering: Noubar Afeyan Enlarge this image Kristen Uroda for NPR Kristen Uroda for NPR In the field of bio-tech, it can take 10 years and millions of dollars to see if an experimental idea might turn into a life-saving treatment—if it ever does. At a breathtaking pace, Moderna produced a prototype for a COVID-19 vaccine, partnered with …

EXPLAINED: Alpha To Delta, One Shot To Beat Them All. Why Multivariant Jabs Could Be Future Of Covid Fight
3 years, 2 months ago

EXPLAINED: Alpha To Delta, One Shot To Beat Them All. Why Multivariant Jabs Could Be Future Of Covid Fight

News 18  

New and emerging variants of the novel coronavirus are seen as being able to dodge antibodies acquired either through vaccination or prior infection. While updated vaccines and additional shots are an option to counter potential future outbreaks — much like how existing vaccines are updated against the seasonal influenza — a single jab that is targeted towards multiple variants can …

AstraZeneca picks up new vaccine technology originally intended to target Covid
3 years, 3 months ago

AstraZeneca picks up new vaccine technology originally intended to target Covid

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Scientists at Imperial College London are partnering with AstraZeneca to develop …

Science behind Pfizer vaccine: Teaching cells to fight Covid-19 via genetic instruction
3 years, 4 months ago

Science behind Pfizer vaccine: Teaching cells to fight Covid-19 via genetic instruction

India Today  

The US Food and Drug Administration Monday granted full approval to the Covid-19 vaccine developed by Pfizer-BioNTech. The decision comes at a time when FDA has allowed emergency use of a booster dose of either the Pfizer or Moderna vaccine for people with severely weakened immune systems. "The full approval by the FDA underlines the vaccine's high efficacy and favourable …

France's Sanofi Expands mRNA Vaccine Drive With US Firm Purchase
3 years, 4 months ago

France's Sanofi Expands mRNA Vaccine Drive With US Firm Purchase

News 18  

France’s pharmaceutical giant Sanofi, which has lagged behind rivals in developing new generation mRNA Covid-19 vaccines, on Tuesday said it has purchased a US firm specialising in the technology. Sanofi was left trailing in the race to break out a Covid-19 vaccine in 2020, as rivals Pfizer-BioNTech and Moderna used pioneering mRNA technology to develop jabs in record time. Sanofi, …

Gennova to use mRNA tech to develop vaccines for Zika, tuberculosis
3 years, 4 months ago

Gennova to use mRNA tech to develop vaccines for Zika, tuberculosis

Business Standard  

Gennova to use mRNA tech to develop vaccines for Zika, tuberculosis mRNA vaccines typically have stringent temperature requirements to remain stable Premium The mRNA vaccine candidate contains a short, synthetic version encoding the spike protein of the novel coronavirus Sars-CoV-2. Sohini Das Mumbai Gennova Biopharmaceuticals, a subsidiary of Pune-headquartered Emcure Pharmaceuticals, is not only developing India’s first indigenous messenger ribonucleic …

The two-shot COVID vaccines require two shots for a good reason: study
3 years, 4 months ago

The two-shot COVID vaccines require two shots for a good reason: study

Salon  

In April, the Centers for Disease Control and Prevention found that millions of Americans who received one shot of the two-dose Pfizer and Moderna vaccines never returned for their second jab. The scientists behind the study found, among other things, that while the first shot does boost SARS-CoV-2-specific antibody levels, getting a second dose boosts antibody levels to a far …

What is a Covid-19 vaccine 'breakthrough' case?
3 years, 4 months ago

What is a Covid-19 vaccine 'breakthrough' case?

India Today  

What is a Covid-19 vaccine “breakthrough” case? If you do end up getting sick despite vaccination, experts say the shots help reduce the severity of the illness — the main reason to get vaccinated. Previously, health officials believed vaccinated people who get breakthrough infections were unlikely to spread the virus. But with the more contagious delta variant that is now …

Breakthrough COVID-19 Infections: What Vaccinated People Need To Know
3 years, 5 months ago

Breakthrough COVID-19 Infections: What Vaccinated People Need To Know

Huff Post  

tommy via Getty Images Perfection wasn't the goal of the COVID-19 vaccines -- preventing hospitalization and death was. “Of course, you’re going to hear stories here and there of people who are fully vaccinated and catch COVID because there are a lot of us out there who are fully vaccinated,” said Megan Ranney, an associate professor of emergency medicine and …

COVID-19 vaccines developed quickly — is an HIV vaccine next?
3 years, 5 months ago

COVID-19 vaccines developed quickly — is an HIV vaccine next?

The Hindu  

Decades on from the start of the HIV/AIDS pandemic, researchers are yet to crack a successful formula for a vaccine. "Science and the globe have been very fortunate that SARS-CoV-2 is an easy target for vaccines," said Jonathan Weber, dean of medicine at Imperial College London and long-term HIV researcher. HIV vaccines in progress To date, only one HIV vaccine, …

Discover Related